Abstract: Imaging devices including a novel imaging system wherein a 2-dimensional pixel array has a diagonal dimension larger than the diameter measurement of the image circle, thereby being capable of handling rectangular images with multiple aspect ratios. These new imaging devices can be used in various electronic imaging apparatus with or without a lens system.

Abstract: A battery pack includes a porous medium positioned in a case. The porous medium hold several batteries. The battery pack also includes terminals for accessing power from the batteries held by the porous medium. The terminals are accessible from outside of the case. The battery pack also includes a flame retardant absorbed into pores of the porous medium.

Abstract: The invention refers to a fully human miniantibody (scFv), called Erbicin, specific for the receptor ErbB2, with a pharmacological, in particular antitumour, activity. It has been obtained from a larger fagmidic library (Griffin 1.) (19) of human synthetic scFv by panning (affinity selection on antigen) carried out on live cells that express various levels of ErbB2. The invention relates also to the DNA and amino acid sequences of said antibody, to the procedure for isolating it, to its use in therapy.

Abstract: Reusing a Si wafer for the formation of wire arrays by transferring the wire arrays to a polymer matrix, reusing a patterned oxide for several array growths, and finally polishing and reoxidizing the wafer surface and reapplying the patterned oxide.

Abstract: The invention provides novel a hybrid slip casting-Electrophoretic Deposition (EPD) process which can be used to produce arbitrary shape geometries with controlled materials properties. The invention provides processes for the fabrication of Functionally Graded Materials (FGM) by a controlled Electrophoretic Deposition (EPD).

Abstract: The disclosure provides an antigenic composition useful for immunization against tularemia. The disclosure provides a method for producing a vaccine for preventing tularemia in humans and animals, a new vaccine against tularemia in humans and animals, and a new approach to producing vaccines against tularemia.

Abstract: Utilization of the E-Metro Community and Personal Information Agents assure an effective and comprehensive agent-rule based command and control of informational assets in a networked computer environment. The concerns of informational privacy and informational self-determination are addressed squarely by the invention affording persons and entities a trusted means to author, secure, search, process, and exchange personal and/or confidential information in a networked computer environment. The formation of trusted electronic communities wherein members command and control their digital persona, exchanging or brokering for value the trusted utility of their informational assets is made possible by the invention. The present invention provides for the trusted utilization of personal data in electronic markets, providing both communities and individuals aggregate and individual rule-based control of the processing of their personal data.

Abstract: Systems and method of managing map data on electronic devices such as portable electronic devices include systems and methods of preloading map data, managing map data storage, sharing point of interest or pushpin data with other electronic devices, and displaying map data.

Abstract: The invention provides a seat track fitting and a corresponding method to lock seats on a known hollow track. In one embodiment, the track is longitudinally provided with a plurality of symmetric circular-shaped openings of a diameter greater than the width of the slot opening comprises a main body mechanism and a shear plunger provided with a screw associated with an anti-loosening component, slidably arranged with respect to the main body mechanism.

Abstract: This disclosure relates to methods and compositions for genetically altering cellulose biosynthesis.

Abstract: A battery is disclosed. The battery includes an electrolyte activating one or more anodes and one or more cathodes. The electrolyte includes one or more salts dissolved in a solvent. The solvent includes one or more first siloxanes and/or one or more first silanes. Each of the first siloxanes and/or first silanes have one or more first substituents that each include a poly(alkylene oxide) moiety. The solvent also includes one or more second siloxanes and/or one or more second silanes. Each of the second siloxanes and/or second silanes have one or more second substituents that each include a carbonate moiety.

Abstract: Provided are methods and compositions for constructing stable mammalian embryonic epithelial tissues and organs as well as constructing kidney tissue, and treating renal failure. Disclosed are methods of using an active epithelial growth factor having the capability of effectuating induction of growth and morphogenesis is cells.

Abstract: The disclosure provides compounds and methods to treat bacterial pathogenesis, and demonstrates that the S. aureus pigment is a virulence factor and potential novel target for antimicrobial therapy.

Abstract: The disclosure relates to metallic nanophotonic crescent structures, or “nanocrescent SERS probes,” that enhance detectable signals to facilitate molecular detections. More particularly, the nanocrescent SERS probes of the disclosure possess specialized geometries, including an edge surrounding the opening that is capable of enhancing local electromagnetic fields. Nanosystems utilizing such structures are particularly useful in the medical field for detecting rare molecular targets, biomolecular cellular imaging, and in molecular medicine.

Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.

Abstract: The present invention relates to the analysis of oxidized phospholipids (OxPL) on apolipoprotein B-100 in patients at high risk or with documented coronary artery disease (CAD) or acute coronary syndromes (ACS) such as unstable angina and acute myocardial infarction or suspected of being at risk for ACS. Such methods are useful for diagnostic purposes and for monitoring the effects of dietary interventions or with drugs such as statins. More particularly, the present invention relates to methods for determining OxPL/apoB ratios as indices of atherosclerosis regression and plaque stability.

Abstract: The disclosure relates generally to neurodegenerative disorders and more specifically to a group of presenilin/G-protein/c-src binding polypeptides and methods of use for modulating signaling and progression of Alzheimer's disease.

Abstract: A consumable bitumen packaging compound including at least one packaging material/s, such as polymers, plastics and extenders and the like, used in combination with the bituminous material and a metal, either pure in powder form or in the form of salt or oxide, that is physically and/or chemically combined with the polymer material, so that the density of the packaging material is adjusted to prevent the material from floating to the surface of the molten material after melting. The components of the packaging are preferably selected such that they are compatible with the bitumen. After transport and storage, the packaging material can therefore be directly incorporated into the bitumen product for final use, such that the formation of a polymer skin accumulating at the surface of the molten material is largely avoided.

Abstract: Electrical structures and devices may be formed and include an organic passivating layer that is chemically bonded to a silicon-containing semiconductor material to improve the electrical properties of electrical devices. In different embodiments, the organic passivating layer may remain within finished devices to reduce dangling bonds, improve carrier lifetimes, decrease surface recombination velocities, increase electronic efficiencies, or the like. In other embodiments, the organic passivating layer may be used as a protective sacrificial layer and reduce contact resistance or reduce resistance of doped regions. The organic passivation layer may be formed without the need for high-temperature processing.

Abstract: Methods and compositions for identifying neoplastic cells in a biological sample are provided.